Accor’s quarterly RevPAR and revenue both surpassed their 2019 levels and by a greater magnitude than in Q2. Trading was supportive in all regions except in Asia, while the zero-COVID policy in China is likely to linger for longer. We expect a minor increase in the consensus but we will maintain our estimates, which are in line with the renewed guidance.
31 Oct 2022
All good but China (and its neighbourhood)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
All good but China (and its neighbourhood)
Accor’s quarterly RevPAR and revenue both surpassed their 2019 levels and by a greater magnitude than in Q2. Trading was supportive in all regions except in Asia, while the zero-COVID policy in China is likely to linger for longer. We expect a minor increase in the consensus but we will maintain our estimates, which are in line with the renewed guidance.